We advocate for the advancement of research and development in cellular therapy, a
groundbreaking field poised to transform medicine by utilizing living cells to treat
diseases. This innovative approach holds immense promise for improving patient
outcomes in areas such as cancer, autoimmune disorders, and genetic diseases.
Collaborating with manufacturers and regulators, we prioritize the safety of donors
and recipients in all research endeavours.
We focus on maximizing the life-saving potential of cord blood, cord tissue, and
placental tissue through enhanced education, collection methods, and consent rates.
Collaborating with obstetricians and midwives, we address maternal health to ensure
optimal volumes of cord blood while striving to reduce global infant and maternal
mortality rates.
We champion vigorous global harmonization of cellular therapy regulations to ensure
safety and efficacy, streamline approval processes, and facilitate international
collaboration. This initiative aims to provide equitable access to high-quality
treatments, boost public confidence, and stimulate economic growth in the biotech
sector. By creating a unified regulatory framework, we seek to accelerate the
development and adoption of innovative cellular therapies worldwide.
We advocate for the cellular therapy industry in public policy, legislation, regulation,
and affordable healthcare delivery by engaging with government, health
professionals, manufacturers, researchers, and donor and recipient groups.
We provide unbiased education and information about stem cells, working with
communities to promote knowledge of their potential.
Our program aims to inform
and educate both the public and healthcare professionals, building community
support through a variety of channels.
These include public awareness days, donor
recruitment events, and our web and social media platforms. By fostering
connections through education, advocacy, and donor recruitment, we strive to turn
innovative ideas into real solutions.